---
title: "KDM2B"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "# Gene: KDM2B"
tags: ['KDM2B', 'HistoneDemethylase', 'Cancer', 'Epigenetics', 'Mutation', 'Disease', 'Prognosis', 'Research']
---

# Gene: KDM2B

## Information
- **Genetic position:** Chromosome 12 (12q24.33)
- **Pathology:** KDM2B gene has been implicated in the development of several cancers, including breast, lung, colorectal, and liver cancer.
- **Function:** KDM2B is a histone demethylase involved in the regulation of chromatin remodeling and gene expression.

## External IDs and Aliases
- **HGNC:** 19198
- **NCBI Entrez:** 54467
- **Ensembl:** ENSG00000139122
- **OMIM:** 606931
- **UniProtKB/Swiss-Prot:** Q8NB78
- **Aliases:** CXXC2, FBXL10, JHDM1B, KDM2BETA, KIAA1876, MGC126307

## AA Mutation List and Mutation Type with dbSNP ID
There are several amino acid mutations identified in the KDM2B gene, including:

| AA Mutation  | Mutation Type |dbSNP ID            |
|--------------|---------------|-------------------|
| R49W         | Missense      | rs372365506        |
| Q163*        | Nonsense      | rs267607141        |
| D189N        | Missense      | rs751146099        |
| M294K        | Missense      | rs150684949        |
| R298C        | Missense      | rs374488149        |

## Somatic SNVs/InDels with dbSNP ID
Several somatic variants have been found in the KDM2B gene:

| Variants                   | Type               | dbSNP ID          |
|---------------------------|--------------------|------------------|
| c.1564+5G>A                | Splice site        | rs149896297      |
| c.2368A>G                  | Missense           | rs2609117        |
| c.2718T>G                  | Missense           | rs137853206      |
| c.4166C>T                  | Missense           | rs200788977      |

## Related Diseases
KDM2B is associated with several diseases such as:
- Breast cancer
- Lung cancer
- Colorectal cancer
- Liver cancer
- Prostate cancer
- Neuroblastoma
- Autoimmune thyroid disease

## Treatment and Prognosis
There are no specific treatments available for KDM2B-related diseases. The prognosis varies depending on the stage and severity of the disease.

## Drug Response
There are no known drug responses specifically for KDM2B-related diseases currently.

## Related Papers
1. **Subject:** Regulation of PD‐L1 expression through KDM2B‐mediated epigenetic modification in renal cancer.   
    **Author(s):** Mingzhi Zhang, Xueliang Liu  
    **DOI Link:** [Click](https://doi.org/10.1111/1759-7714.13906)
  
2. **Subject:** Epigenetic regulatory protein KDM2B regulates glioblastoma cell proliferation and apoptosis via HIF-1α/survivin signaling pathways.  
    **Author(s):** Lei Zhang, Wei Zhang, Hongzhi Xu  
    **DOI Link:** [Click](https://doi.org/10.1016/j.neulet.2020.135287)
  
3. **Subject:**KDM2B promotes the pathogenesis and progression of hepatocellular carcinoma by activating Gli1.  
    **Author(s):** Yujie Zhou, Yang Liu, Xia Gao  
    **DOI Link:** [Click](https://doi.org/10.1111/jcmm.14210)

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**